P093 INFLIXIMAB REINTRODUCTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE PREVIOUSLY TREATED WITH A 3-INFUSION INDUCTION REGIMEN IS NOT ASSOCIATED TO A HIGHER RATE OF IMMUNE-MEDIATED ADVERSE EFFECTS
| Autor: | Zabana, Y., Domènech, E., Cabré, E., Mañosa, M., García-Castellanos, R., Carrión, S., Ortiz, T., Gassull, M. |
|---|---|
| Zdroj: | In Journal of Crohn's and Colitis Supplements 2008 2(1):33-33 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|